+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology Neuromodulation, and Internal Neuromodulation; Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depressio

  • ID: 5231423
  • Report
  • November 2020
  • Region: Asia Pacific
  • 117 pages
  • The Insight Partners
UP TO OFF
until Jan 31st 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • Magstim
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • MORE
According to the latest study on ‘Asia Pacific Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology, Application, End User, and Country’ the Asia Pacific Neuromodulation market was valued at US$ 1,559.89 million in 2019 and is projected to reach US$ 3,518.34 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020-2027. The report highlights the trends prevailing in the Asia Pacific neuromodulation market and the factors driving the market along with those that act as deterrents to its growth.

Based on technology, the neuromodulation market is segmented external (non-invasive) neuromodulation and internal neuromodulation. In 2019, the internal neuromodulation segment accounted for the largest share of the Asia Pacific neuromodulation market. The growth of the segment attributes to growth of internal neuromodulation segment is attributed to increasing product launches in the market, the rising product innovation for neuromodulation devices and growing developments in neuromodulation technology are some of the primary factors contributing to the dominance of the segment in the Asia Pacific Neuromodulation market. Additionally, the outbreak of the COVID-19 pandemic has highly affected the countries in the Asia Pacific region.

Abbott, Boston Scientific Corporation, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., NEVRO CORP, Synapse Biomedical Inc., Soterix Medical Inc, Integer Holdings Corporation, and Magstim. are among the prominent players present in the neuromodulation market. The market players are focused on mergers and acquisitions to sustain their position in the market. For instance, in September 2020 Boston Scientific announced the Asia Pacifican launch of the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) Systems. The portfolio, consisting of four MRI conditional, Bluetooth-enabled implantable pulse generators (IPGs), offers expanded personalization based on patient needs, including rechargeable and non-rechargeable options, and access to waveforms that can cover multiple areas of pain.

The report segments the Asia Pacific neuromodulation market as follows:

By Technology
  • External (Non-Invasive) Neuromodulation
  • Respiratory Electrical Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Internal Neuromodulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
  • Spinal Cord Stimulation
  • Vagus Nerve StimulationBy Application
  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Obsessive-Compulsive Disorder
  • Migraine
By End User
  • Hospitals
  • Clinics
  • Home Healthcare
By Country
  • Japan
  • China
  • India
  • South Korea
  • Australia
Reasons to Buy
  • Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific neuromodulation market
  • Highlights key business priorities to assist companies in order to realign their business strategies
  • Highlights key findings and recommendations of crucial progressive industry trends in the Asia Pacific neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinizes in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Magstim
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia-Pacific Neuromodulation Market - by Technology
1.3.2 Asia-Pacific Neuromodulation Market - by Application
1.3.3 Asia-Pacific Neuromodulation Market - by End User
1.3.4 Asia-Pacific Neuromodulation Market - by Country

2. Neuromodulation Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia-Pacific Neuromodulation- Market Landscape
4.1 Overview
4.2 PEST Analysis
Expert Opinions

5. Neuromodulation Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Neurological Disorders
5.1.2 Growing Developments in Neuromodulation Technology
5.2 Market Restraints
5.2.1 High Cost of Neuromodulation Devices
5.3 Market Opportunities
5.3.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain
5.4 Future Trends
5.4.1 Technological Advancements
5.5 Impact Analysis

6. Neuromodulation Market Analysis - by Technology
6.1 Overview
6.2 Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
6.3 External Neuromodulation
6.3.1 Overview
6.3.2 External Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.3.3 Respiratory Electrical Stimulation (RES)
6.3.3.1 Overview
6.3.3.2 Respiratory Electrical Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
6.3.4.1 Overview
6.3.4.2 Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.3.5 Transcranial Magnetic Stimulation (TMS)
6.3.5.1 Overview
6.3.5.2 Transcranial Magnetic Stimulation (TMS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4 Internal Neuromodulation
6.4.1 Overview
6.4.2 Internal Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.3 Deep Brain Stimulation (DBS)
6.4.3.1 Overview
6.4.3.2 Deep Brain Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.4 Sacral Nerve Stimulation (DBS)
6.4.4.1 Overview
6.4.4.2 Sacral Nerve Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.5 Gastric Electric Stimulation (GES)
6.4.5.1 Overview
6.4.5.2 Gastric Electric Stimulation (GES): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.6 Spinal Cord Stimulation (SCS)
6.4.6.1 Overview
6.4.6.2 Spinal Cord Stimulation (SCS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
6.4.7 Vagus Nerve Stimulation (VNS)
6.4.7.1 Overview
6.4.7.2 Vagus Nerve Stimulation (VNS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

7. Neuromodulation Market Analysis - by Application
7.1 Overview
7.2 Neuromodulation Market Share, by Application, 2019 and 2027 (%)
7.3 Chronic Pain Management
7.3.1 Overview
7.3.2 Chronic Pain Management: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Failed Back Syndrome
7.4.1 Overview
7.4.2 Failed Back Syndrome: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Epilepsy
7.5.1 Overview
7.5.2 Epilepsy: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Tremor
7.6.1 Overview
7.6.2 Tremor: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Incontinence
7.7.1 Overview
7.7.2 Incontinence: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Depression
7.8.1 Overview
7.8.2 Depression: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.9 Dystonia
7.9.1 Overview
7.9.2 Dystonia: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.10 Gastroparesis
7.10.1 Overview
7.10.2 Gastroparesis: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.11 Parkinson’s Disease
7.11.1 Overview
7.11.2 Parkinson’s Disease: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.12 Obsessive-Compulsive Disorder (OCD)
7.12.1 Overview
7.12.2 Obsessive-Compulsive Disorder: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
7.13 Migraine
7.13.1 Overview
7.13.2 Migraine: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

8. Neuromodulation Market Analysis - by End User
8.1 Overview
8.2 Neuromodulation Market Share, by End User, 2019 and 2027, (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Clinics
8.4.1 Overview
8.4.2 Clinics: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Home Healthcare
8.5.1 Overview
8.5.2 Home Healthcare: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

9. Neuromodulation Market Analysis and Forecasts to 2027 - Regional Analysis
9.1 Asia Pacific: Neuromodulation Market
9.1.1 Overview
9.1.2 Asia Pacific: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.3.1 Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.3.2 Asia Pacific: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.4 Asia Pacific: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.5 Asia Pacific: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.6 Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)
9.1.7 China: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 China: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 China: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 China: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 China: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.3 China: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.7.4 China: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.8 Japan: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Japan: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Japan: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.1 Japan: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 Japan: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Japan: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.8.4 Japan: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.9 India: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.1 India: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.9.2 India: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.9.2.1 India: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.9.2.2 India: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.9.3 India: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.9.4 India: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.10 South Korea: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.1 South Korea: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.10.2 South Korea: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.10.2.1 South Korea: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.10.2.2 South Korea: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.10.3 South Korea: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.10.4 South Korea: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.11 Australia: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.1 Australia: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
9.1.11.2 Australia: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
9.1.11.2.1 Australia: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.11.2.2 Australia: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.11.3 Australia: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
9.1.11.4 Australia: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)

10. Impact of COVID-19 Pandemic on Asia Pacific Neuromodulation Market
10.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11. Company Profiles
11.1 Abbott
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Boston Scientific Corporation
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Medtronic
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 NeuroPace, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 NeuroSigma, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Nevro Corp.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Synapse Biomedical Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Soterix Medical Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Integer Holdings Corporation
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Magstim
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix
12.1 Glossary of Terms

List of Tables
Table 1. Asia Pacific: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 6. China: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 7. China: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 8. China: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 9. China: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. China: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 11. Japan: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 12. Japan: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 13. Japan: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Japan: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. Japan: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 16. India: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 17. India: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 18. India: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 19. India: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. India: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. South Korea: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 22. South Korea: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. South Korea: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 24. South Korea: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 25. South Korea: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 26. Australia: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 27. Australia: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 28. Australia: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 29. Australia: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 30. Australia: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 31. Glossary of Terms, Neuromodulation Market

List of Figures
Figure 1. Neuromodulation Market Segmentation
Figure 2. Asia-Pacific Neuromodulation Market - by Country
Figure 3. Asia-Pacific Neuromodulation Market Overview
Figure 4. Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market
Figure 5. Asia-Pacific Region is Expected to show Remarkable Growth during the Forecast Period
Figure 6. Asia-Pacific Neuromodulation Market - Leading Country Markets (US$ Million)
Figure 7. Asia Pacific PEST Analysis
Figure 8. Neuromodulation Market Impact Analysis of Drivers and Restraint
Figure 9. Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
Figure 10. External Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 11. Respiratory Electrical Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Transcranial Magnetic Stimulation (TMS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Internal Neuromodulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Deep Brain Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Sacral Nerve Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Gastric Electric Stimulation: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Spinal Cord Stimulation (SCS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Vagus Nerve Stimulation (VNS): Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Neuromodulation Market Share, by Application, 2019 and 2027 (%)
Figure 21. Chronic Pain Management: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Failed Back Syndrome: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Epilepsy: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Tremor: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Incontinence: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Depression: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Dystonia: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Gastroparesis: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Parkinson’s Disease: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Obsessive-Compulsive Disorder: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Migraine: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Neuromodulation Market Share, by End User, 2019 and 2027 (%)
Figure 33. Hospitals Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 34. Clinics: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 35. Home Healthcare: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
Figure 36. Asia Pacific: Neuromodulation Market, by Key Country - Revenue (2019) (USD Million)
Figure 37. Asia Pacific: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
Figure 38. Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)
Figure 39. China: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 40. Japan: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. India: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. South Korea: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Australia: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Note: Product cover images may vary from those shown
3 of 3
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim
Note: Product cover images may vary from those shown
Adroll
adroll